We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+28.45%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$452B
AUM Growth
+$83.8B
Cap. Flow
-$1.84B
Cap. Flow %
-0.41%
Top 10 Hldgs %
16.9%
Holding
6,941
New
185
Increased
3,288
Reduced
2,645
Closed
222

Sector Composition

Rank Sector Weight
1 Technology 19.32%
2 Healthcare 10.4%
3 Consumer Discretionary 8.1%
4 Communication Services 7.82%
5 Financials 7.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RFG icon
1726
Invesco S&P MidCap 400 Pure Growth ETF
RFG
$341M
$13.1M ﹤0.01%
434,015
-1,820
-0.4% -$49.5K
ITCI
1727
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$13M ﹤0.01%
508,191
-33,099
-6% -$670K
RIV
1728
RiverNorth Opportunities Fund
RIV
$313M
$13M ﹤0.01%
878,862
+67,730
+8% +$920K
CPRX
1729
DELISTED
Catalyst Pharmaceutical
CPRX
$13M ﹤0.01%
2,820,035
+107,406
+4% +$483K
ACGL icon
1730
Arch Capital
ACGL
$34.3B
$13M ﹤0.01%
454,672
+45,965
+11% +$1.27M
NGVT icon
1731
Ingevity
NGVT
$2.53B
$13M ﹤0.01%
247,452
+137,968
+126% +$6.55M
MOH icon
1732
Molina Healthcare
MOH
$10.3B
$13M ﹤0.01%
73,028
-2,054
-3% -$350K
SPTL icon
1733
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.6B
$13M ﹤0.01%
276,696
+42,413
+18% +$2M
CGBD icon
1734
Carlyle Secured Lending
CGBD
$711M
$13M ﹤0.01%
1,514,332
-241,507
-14% -$1.88M
MINI
1735
DELISTED
Mobile Mini Inc
MINI
$13M ﹤0.01%
439,861
-54,809
-11% -$1.63M
AIVL icon
1736
WisdomTree US AI Enhanced Value Fund
AIVL
$430M
$12.9M ﹤0.01%
175,380
-16,291
-8% -$1.17M
CASY icon
1737
Casey's General Stores
CASY
$31.8B
$12.9M ﹤0.01%
86,206
+33,863
+65% +$5.1M
GNTX icon
1738
Gentex
GNTX
$5.01B
$12.9M ﹤0.01%
499,965
-206,090
-29% -$5.16M
BSJM
1739
DELISTED
Invesco BulletShares 2022 High Yield Corporate Bond ETF
BSJM
$12.9M ﹤0.01%
577,594
+188,057
+48% +$4.17M
CLS icon
1740
Celestica
CLS
$38.1B
$12.9M ﹤0.01%
1,883,356
-1,346,760
-42% -$7.7M
IGLB icon
1741
iShares 10+ Year Investment Grade Corporate Bond ETF
IGLB
$2.83B
$12.9M ﹤0.01%
183,539
+31,235
+21% +$2.09M
PZZA icon
1742
Papa John's
PZZA
$1.03B
$12.8M ﹤0.01%
161,695
+1,812
+1% +$135K
SAM icon
1743
Boston Beer
SAM
$1.92B
$12.8M ﹤0.01%
23,910
+7,265
+44% +$3.52M
DHR.PRA
1744
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
$12.8M ﹤0.01%
10,220
+5,192
+103% +$6.12M
GILT icon
1745
Gilat Satellite Networks
GILT
$873M
$12.8M ﹤0.01%
2,010,601
+1,746,474
+661% +$13.4M
PDX
1746
PIMCO Dynamic Income Strategy Fund
PDX
$955M
$12.8M ﹤0.01%
1,810,188
-189,419
-9% -$1.43M
PTF icon
1747
Invesco Dorsey Wright Technology Momentum ETF
PTF
$604M
$12.8M ﹤0.01%
393,384
+55,665
+16% +$1.54M
XHS icon
1748
State Street SPDR S&P Health Care Services ETF
XHS
$208M
$12.8M ﹤0.01%
187,466
+39,332
+27% +$2.54M
EVA
1749
DELISTED
Enviva Inc.
EVA
$12.7M ﹤0.01%
353,735
+22,677
+7% +$753K
ERUS
1750
DELISTED
iShares MSCI Russia ETF
ERUS
$12.7M ﹤0.01%
380,773
+180,904
+91% +$5.88M

Similar funds

Morgan Stanley's Q2 2020 Portfolio in Review

As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
  • Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
  • Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
  • Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
  • Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
  • Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
  • Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.

Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.